Literature DB >> 29909851

May-Thurner syndrome and the risk of pulmonary embolism in patients with acute deep venous thrombosis.

Song Jin1, Ziqiang Sun2, Xiaoqin Li3, Tao Jian2, Xing Jin4, Sheng Li5, Guodong Wang2, Chong Ma2, Kai Cui5, Peng Xu6.   

Abstract

OBJECTIVE: Pulmonary embolism (PE) is the most common complication of deep venous thrombosis (DVT). May-Thurner syndrome (MTS) is known to increase the risk of DVT, but an association between MTS and PE has not been established. This study investigated an association between MTS and the risk of PE in patients with acute lower extremity DVT.
METHODS: Between June 2014 and September 2016, there were 112 patients with DVT at our hospital who underwent venous angiography and computed tomography pulmonary angiography. Data related to the patients' demographics, risk factors, disease onset time, side of DVT, D-dimer level, Doppler ultrasound, venous angiography, and computed tomography pulmonary angiography were collected. Associations between MTS and PE were analyzed.
RESULTS: The 112 DVT patients included 79 with MTS. The rate of DVT in the left lower extremity was higher in the MTS group (98.7%) than in the non-MTS group (48.5%; P < .001). PE was less common in the MTS group (50.6%) than in the non-MTS group (78.8%; P = .006). The multinomial logistic analysis revealed a significant negative correlation between MTS and PE. The correlation remained after applying adjustment models I, II, and III. Model I adjusted for risk factors, DVT side, and D-dimer tertile (odds ratio [OR], 0.17; 95% confidence interval [CI], 0.04-0.68; P = .0125); model II adjusted for sex, age, risk factors, onset time, DVT side, D-dimer level, and D-dimer tertile (OR, 0.15; 95% CI, 0.03-0.71; P = .0162); and model III adjusted for sex, age, risk factors, onset time, DVT side, D-dimer level, D-dimer tertile, iliofemoral DVT, mixed (both iliofemoral and femoropopliteal) DVT, and femoropopliteal DVT (OR, 0.35; 95% CI, 0.06-2.08; P = .2501).
CONCLUSIONS: DVT patients with concomitant MTS have a decreased risk of PE compared with those without MTS. This finding extends previous reports of increased PE risk after DVT and calls for better understanding of shared risk factors and underlying mechanisms.
Copyright © 2018 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deep venous thrombosis; May-Thurner syndrome; Pulmonary embolism

Mesh:

Substances:

Year:  2018        PMID: 29909851     DOI: 10.1016/j.jvsv.2018.01.007

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  5 in total

1.  Percutaneous endovenous intervention without vena cava filter for acute proximal deep vein thrombosis secondary to iliac vein compression syndrome: preliminary outcomes.

Authors:  Qiaohua Zhu; Dehua Chen; Chengyu Zhou; Meihua Luo; Wei Huang; Jiangyuan Huang; Junyong Huang; Yong Chen
Journal:  Radiol Med       Date:  2021-01-04       Impact factor: 3.469

2.  Clinical outcomes of AngioJet rheolytic thrombectomy in the treatment of May-Thurner syndrome-related deep venous thrombosis.

Authors:  Wen-Cheng Wei; Chun-Hsien Hsin; Hsuan-Tzu Yang; Ta-Wei Su; I-Hao Su; Sung-Yu Chu; Po-Jen Ko; Sheng-Yueh Yu; Chun-Hui Lee
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

3.  Left lower limb deep venous thrombosis, May-Thurner syndrome and endovascular management.

Authors:  Khawaja B Waheed; Hassan R Mohammed; Khaled S Salem; Mohamed A Shaltout; Ali S Alshehri; Emad F Said; Abdulhadi S Almubarak; Zechariah J Arulanantham
Journal:  Saudi Med J       Date:  2022-01       Impact factor: 1.422

4.  Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine.

Authors:  Xiaoyi Zhang; Yixin Zhang; Yaonan Wang; Jianhui Wu; Haiyan Chen; Ming Zhao; Shiqi Peng
Journal:  Int J Nanomedicine       Date:  2020-01-21

Review 5.  Review of imaging and endovascular intervention of iliocaval venous compression syndrome.

Authors:  Ming Ren Toh; Tjun Yip Tang; Han Hui Mervin Nathan Lim; Nanda Venkatanarasimha; Karthikeyan Damodharan
Journal:  World J Radiol       Date:  2020-03-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.